Key Points

In Week 32, epidemiological indicators showed that the SARS-CoV-2 virus was still circulating widely in the Île-de-France region. The incidence rate was rising moderately, and new hospitalizations and admissions to intensive care continued to increase amid widespread transmission of the Delta variant, declining public adherence to preventive measures, and still-incomplete vaccination coverage.
In Île-de-France, the regional incidence rate for Week 32 was 200 cases per 100,000 inhabitants, a slight increase following two weeks of stabilization. At the departmental level, disparities were still observed, with a decline in the incidence rate in Paris and the Hauts-de-Seine department and an increase in all other departments in the region. Contrary to the trend observed in S31, the regional testing rate rose sharply in S32. The positivity rate, meanwhile, declined.

In S32, the proportion of primary care visits for “suspected COVID-19” decreased slightly among SOS Médecins clinics but continued to rise in emergency departments. At the hospital level, new hospitalizations, admissions to intensive care, and the number of new deaths in hospitals continued to rise in S32.

As of August 16, 67.9% of the Île-de-France population of all ages had received at least one vaccine dose, and 58% were fully vaccinated. In Week 32, the rate of increase in vaccination coverage continued to decline for all age groups compared to previous weeks.
Against a backdrop of significant viral circulation, widespread transmission of the Delta variant, and summer vacations, vaccination of all eligible individuals—particularly those in contact with vulnerable people—must continue to be strongly encouraged and must be accompanied by high adherence to other preventive measures.